GENEVA — Making what it calls its first big move into “brain health” products, Swiss food and drinks giant Nestlé SA has acquired a stake in a privately held Broomfield healthcare company that makes a milkshake prescribed to Alzheimer’s patients, a Nestle executive told The Associated Press on Wednesday.

The Vevey, Switzerland-based company’s undisclosed stake gives it status as the biggest minority shareholder in Accera, a company that makes the milkshake, said Luis Cantarell, president and CEO of Nestlé Health Science SA, a wholly owned subsidiary. Exact terms of the transaction were not disclosed.

Cantarell said the acquisition could eventually help expand the Nestlé line of medical food products.

“If you look from a financial point of view, this is a very small investment. If you look from a strategic point of view, which is why we created Nestlé Health Science, this is a big hallmark towards promoting medical food as a source of an element to present and to help people manage chronic conditions like Alzheimer’s,” Cantarell told AP in an interview.

Accera’s calorie packets, branded as “Axona” are prescribed to some 30,000 Alzheimer’s patients.

The company says the milkshake, sold in vanilla and strawberry flavors, contains a compound made from coconut oil that is metabolized in a way that can serve as fuel for the brain, which in Alzheimer’s patients isn’t able to convert glucose into energy as efficiently as possible.

The deal will give Cantarell a seat on Accera’s newly expanded board of directors, on which Nestlé already has one representative. Nestlé will then have two of six board seats on Accera, in which Nestlé’s venture capital fund first invested in 2004.

A spokesman for Accera could not immediately be reached Wednesday.

Since it is sold as medical food, the Axona milkshake must meet truth-in-labeling requirements but doesn’t need U.S. Food and Drug Administration approval.

Accera has been paying for clinical trials to try to overcome some skepticism among medical experts and prove the milkshake is effective, Cantarell said, adding that Nestlé’s aim is to provide its expertise and guidance for the research.

“We do this because we believe this will be a big thing. We’re trying to plant a seed to create a future,” he said. “From this new untapped territory of nutrition and the brain, that’s the first, and that’s why we’re very much excited.”

More in Business

After the San Francisco Bay Area, metro Denver experienced the biggest apartment rent increases this decade in the country. But plenty of new supply should put future rent gains closer to the national average, according to a new report from RealPage, a real estate research firm.

Strong consumer spending, coupled with a booming stock market, the federal tax overhaul and a resurgent oil and gas industry are projected to grow the Colorado state general fund by as much as $1.3 billion next fiscal year.

Facebook plunged to its worst loss in four years Monday and led a rout in technology companies. The social media company's stock fell following reports that a data mining firm working for the Trump campaign improperly obtained data on 50 million Facebook users.